Measurement of Sweat Sodium Concentration in Patients With Chronic Kidney Disease
NCT ID: NCT06354842
Last Updated: 2024-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64 participants
OBSERVATIONAL
2018-10-05
2020-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this cross-sectional feasibility study, we applied pilocarpine iontophoresis to induce sweat testing in 58 patients across various stages of CKD including patients after kidney transplantation as well as a healthy control cohort (n=6) to investigate possible effects of CKD and transplantation status on sweat rate and sodium concentration. Due to non-linear relationships, we modeled our data using polynomial regression.
Decline of kidney function showed a significant association with lower sweat rates: adj R²= 0.2278, F(2, 61) = 10.29, p = 0.000141. Sweat sodium concentrations were increased in moderate CKD, however this effect was lost in end stage renal disease: adj R² = 0.3701, F(4, 59) = 10.26, p = 2.261e-06. We observed higher sweat weight in males compared to females.
Diagnostic sweat analysis represents an innovative and promising noninvasive option for more thorough investigation of sodium- and fluid homeostasis in CKD patients. Lower sweat rates and higher sweat sodium concentrations represent a unique feature of CKD patients with potential therapeutic implications.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney Disease
NCT01623661
The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects
NCT01414088
Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients
NCT06358365
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NCT07020104
Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium
NCT00324883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Healthy control subjects
pilocarpine iontopheresis
Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry
CKDI
Patients with chronic kidney disease G1
pilocarpine iontopheresis
Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry
CKDII
Patients with chronic kidney disease G2
pilocarpine iontopheresis
Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry
CKDIIIa
Patients with chronic kidney disease G3a
pilocarpine iontopheresis
Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry
CKDIIIb
Patients with chronic kidney disease G3b
pilocarpine iontopheresis
Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry
CKDIV
Patients with chronic kidney disease G4
pilocarpine iontopheresis
Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry
CKDV
Patients with chronic kidney disease G5
pilocarpine iontopheresis
Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry
CKDVd
Patients with chronic kidney disease G5 receiving hemodialysis
pilocarpine iontopheresis
Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pilocarpine iontopheresis
Application of pilocarpine on the skin of the patients/subjects to induce sweat production to analyse sweat sodium concentration via flame photometry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tarik Shoumariyeh
Clinical resident & PhD student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johannes Kovarik, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shoumariyeh T, Logar F, Helk O, Hofer J, Schmetterer KG, Mersi B, Gruber S, Saemann MD, Kaltenecker CC, Kovarik JJ. Decline of kidney function is associated with lower sweat weight in patients with chronic kidney disease. Sci Rep. 2025 Jul 2;15(1):22518. doi: 10.1038/s41598-025-05855-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12345678
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.